BRIEF published on 04/04/2024 at 15:05, 1 year 8 months ago First Phase 2 Clinical Trial of Lassa Fever Vaccine Begins in Nigeria Phase 2 Clinical Trial Global Health Lassa Fever Vaccine IAVI CEPI
PRESS RELEASE published on 04/04/2024 at 15:00, 1 year 8 months ago Participants in Nigeria Vaccinated in First-Ever Phase 2 Lassa Fever Vaccine Clinical Trial, Sponsored by IAVI CEPI-funded study in Nigeria evaluates safety, tolerability, and immunogenicity of IAVI's Lassa fever vaccine candidate. First Phase 2 trial for any Lassa vaccine Phase 2 Trial IAVI CEPI Lassa Fever Vaccine Candidate
PRESS RELEASE published on 12/18/2023 at 15:00, 1 year 11 months ago IAVI and Zendal Announce Funding for Efficacy Trial of Promising TB Vaccine Candidate in Africa
PRESS RELEASE published on 07/07/2023 at 15:00, 2 years 4 months ago Germany Issues Award to IAVI to Support Development of the MTBVAC Tuberculosis Vaccine Candidate
PRESS RELEASE published on 06/27/2023 at 15:00, 2 years 5 months ago IAVI Starts First-in-Human Phase I Clinical Trial of Single-Dose Sudan Virus Vaccine Candidate
PRESS RELEASE published on 05/17/2023 at 15:00, 2 years 6 months ago Zendal and IAVI Announce Expanded Agreement to Partner on Development of TB Vaccine Candidate MTBVAC
PRESS RELEASE published on 03/02/2023 at 15:00, 2 years 9 months ago IAVI and BARDA Expand Partnership to Advance IAVI's Filovirus Vaccine Candidates
Published on 12/05/2025 at 02:35, 5 hours 35 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 10 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 5 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 10 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 08:01, 9 minutes ago Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:00, 10 minutes ago Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 07:00, 1 hour 10 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 40 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 19 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 18:14, 13 hours 55 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 10 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 10 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 25 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 25 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
